J2730 HCPCS Level II code: Injection, pralidoxime chloride, up to 1 gm
J2730 is the HCPCS code for “Injection, pralidoxime chloride, up to 1 gm” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2730Injection, pralidoxime chloride, up to 1 gm
Short description: Pralidoxime chloride inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J2730 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
Where J2730 sits
- 1J codesDrugs administered other than orally
- 2Active code J2730Injection, pralidoxime chloride, up to 1 gm
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2730 mean?
J2730 is the HCPCS code for “Injection, pralidoxime chloride, up to 1 gm” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2730?
CMS lists J2730’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2730
All J codesJ2704Injection, propofol, 10 mgJ2710Injection, neostigmine methylsulfate, up to 0.5 mgJ2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mgJ2720Injection, protamine sulfate, per 10 mgJ2724Injection, protein c concentrate, intravenous, human, 10 iuJ2725Injection, protirelin, per 250 mcgJ2760Injection, phentolamine mesylate, up to 5 mgJ2765Injection, metoclopramide hcl, up to 10 mgJ2770Injection, quinupristin/dalfopristin, 500 mg (150/350)J2777Injection, faricimab-svoa, 0.1 mgJ2778Injection, ranibizumab, 0.1 mgJ2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg